-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Mesenchymal Stem/Stromal Cell (Msc) Exosome Ointment in Psoriasis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Mesenchymal Stem/Stromal Cell (Msc) Exosome Ointment in Psoriasis Drug Details:Cell therapy under development for the treatment...
-
Product Insights
MSC – Isla Margarita Port Terminal – Colon
Equip yourself with the essential tools needed to make informed and profitable decisions with our MSC - Isla Margarita Port Terminal - Colon report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Fincantieri/ MSC Cruises – PortMiami Cruise Terminal – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Fincantieri/ MSC Cruises - PortMiami Cruise Terminal - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
MSC/ Saigon Port/ Vinamarin – Can Gio International Container Transshipment Port – Ho Chi Minh City
Equip yourself with the essential tools needed to make informed and profitable decisions with our MSC/ Saigon Port/ Vinamarin - Can Gio International Container Transshipment Port - Ho Chi Minh City report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report?...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CBAC-02 in Alzheimer’s Disease
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDataÂ’s proprietary machine learning algorithms developed using over 10 years of historical data. CBAC-02 in Alzheimer's Disease Drug Details: CBAC-02 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IMS-001 in Primary Progressive Multiple Sclerosis (PPMS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.IMS-001 in Primary Progressive Multiple Sclerosis (PPMS) Drug Details:IMS-001 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IMS-001 in Secondary Progressive Multiple Sclerosis (SPMS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.IMS-001 in Secondary Progressive Multiple Sclerosis (SPMS) Drug Details:IMS-001 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IMS-001 in Relapsing Remitting Multiple Sclerosis (RRMS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.IMS-001 in Relapsing Remitting Multiple Sclerosis (RRMS) Drug Details:IMS-001 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – It-hMSC in Ageing
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.It-hMSC in AgeingDrug Details:Stem cell therapy (Stemedyne-MSC) is under development for the treatment of non-ischemic heart...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – It-hMSC in Dementia Associated With Alzheimer’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.It-hMSC in Dementia Associated With Alzheimer's DiseaseDrug Details:Stem cell therapy (Stemedyne-MSC) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – it-hMSC in Dermatological Disorders
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.It-hMSC in Dermatological Disorders Drug Details:Stem cell therapy (Stemedyne-MSC) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – it-hMSC in Ischemic Stroke
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.It-hMSC in Ischemic Stroke Drug Details:Stem cell therapy (Stemedyne-MSC) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CFMEV-107 in Crohn’s Disease (Regional Enteritis)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. CFMEV-107 in Crohn's Disease (Regional Enteritis) Drug Details: CFMEV-107 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Remestemcel-L in Ulcerative Colitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Remestemcel-L in Ulcerative Colitis Drug Details: Remestemcel-L (Prochymal, Temcell) is a stem cell drug therapy....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Mesenchymal Stem Cells-Derived Exosomes in Acute Respiratory Distress Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Mesenchymal Stem Cells-Derived Exosomes in Acute Respiratory Distress Syndrome Drug Details: The drug candidate is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Mesenchymal Stem Cells-Derived Exosomes in Dermatomyositis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Mesenchymal Stem Cells-Derived Exosomes in Dermatomyositis Drug Details: The drug candidate is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DB-001 in Crohn’s Disease (Regional Enteritis)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. DB-001 in Crohn's Disease (Regional Enteritis) Drug Details: DB-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DB-001 in Ulcerative Colitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. DB-001 in Ulcerative Colitis Drug Details: DB-001 is under development for the treatment of moderate-to-severe...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DB-001 in Acute Respiratory Distress Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. DB-001 in Acute Respiratory Distress Syndrome Drug Details: DB-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DB-001 in Transplant Rejection
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. DB-001 in Transplant Rejection Drug Details: DB-001 is under development for the treatment of moderate-to-severe...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.